Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-May-24 8:56 PM View:  | Evolus, Inc. (EOLS) | 10-May-24 | Private Sale | 16,051 | $12.72 | $204,127.00 | (2%) 689.61K to 673.56K | |
| 29-Mar-24 7:08 PM View: | Evolus, Inc. (EOLS) | 27-Mar-24 | Private Sale | 6,236 | $13.86 | $86,431.00 | (< 1%) 695.85K to 689.61K | |
| 21-Mar-24 6:08 PM View: | Evolus, Inc. (EOLS) | 19-Mar-24 | Private Sale | 96,566 | $13.92 | $1,344,600.00 | (12%) 792.42K to 695.85K | |
| 23-Feb-24 8:27 PM View: | Evolus, Inc. (EOLS) | 22-Feb-24 | Sale (Planned) | 7,706 | $13.08 | $100,804.00 | (< 1%) 800.12K to 792.42K | |
| 23-Feb-24 8:27 PM View: | Evolus, Inc. (EOLS) | 21-Feb-24 | Grant | 61,202 | -- | -- | 8% 738.92K to 800.12K | |
| 09-Feb-24 6:35 PM View: | Evolus, Inc. (EOLS) | 07-Feb-24 | Grant | 134,976 | -- | -- | 22% 603.94K to 738.92K | |
| 08-Dec-23 6:15 PM View: | Evolus, Inc. (EOLS) | 08-Dec-23 | Sale | 31,300 | $9.73 | $304,505.00 | (5%) 635.24K to 603.94K | |
| 08-Dec-23 6:15 PM View: | Evolus, Inc. (EOLS) | 06-Dec-23 | Private Sale | 51,348 | $10.09 | $517,891.00 | (7%) 686.59K to 635.24K | |
| 16-Aug-23 8:25 PM View: | Evolus, Inc. (EOLS) | 16-Aug-23 | Sale (Planned) | 14,778 | $10.27 | $151,770.00 | (2%) 701.37K to 686.59K | |
| 16-Aug-23 8:25 PM View: | Evolus, Inc. (EOLS) | 14-Aug-23 | Grant | 91,803 | -- | -- | 15% 609.57K to 701.37K | |
| 29-Mar-23 5:11 PM View: | Evolus, Inc. (EOLS) | 27-Mar-23 | Private Sale (Planned) | 6,110 | $8.47 | $51,751.70 | (< 1%) 615.68K to 609.57K | |
| 16-Mar-23 10:00 PM View: | Evolus, Inc. (EOLS) | 14-Mar-23 | Private Sale (Planned) | 64,211 | $8.47 | $543,796.00 | (9%) 679.89K to 615.68K | |
| 27-Jan-23 7:24 PM View: | Evolus, Inc. (EOLS) | 25-Jan-23 | Grant | 187,927 | -- | -- | 38% 491.96K to 679.89K | |
| 18-May-22 8:21 PM View: | Evolus, Inc. (EOLS) | 16-May-22 | Private Sale | 55,321 | $13.64 | $754,307.00 | (10%) 547.28K to 491.96K | |
| 30-Mar-22 7:02 PM View: | Evolus, Inc. (EOLS) | 28-Mar-22 | Private Sale (Planned) | 6,104 | $11.62 | $70,928.50 | (1%) 553.39K to 547.28K | |
| 10-Mar-22 7:24 PM View: | Evolus, Inc. (EOLS) | 08-Mar-22 | Private Sale (Planned) | 37,972 | $9.73 | $369,293.00 | (6%) 591.36K to 553.39K | |
| 26-Jan-22 9:03 PM View: | Evolus, Inc. (EOLS) | 24-Jan-22 | Grant | 214,286 | -- | -- | 57% 377.07K to 591.36K | |
| 17-Aug-21 8:24 PM View: | Evolus, Inc. (EOLS) | 16-Aug-21 | Market Sale | 47,737 | $11.35 | $541,739.00 | (11%) 424.81K to 377.07K | 1% |
| 17-Aug-21 8:24 PM View: | Evolus, Inc. (EOLS) | 13-Aug-21 | Market Sale | 22,708 | $10.66 | $242,072.00 | (5%) 447.52K to 424.81K | (5%) |
| 12-Aug-21 6:44 PM View: | Evolus, Inc. (EOLS) | 10-Aug-21 | Market Sale (Planned) | 41,763 | $11.18 | $466,839.00 | 9% 489.28K to 531.04K | (2%) |
| 26-Mar-21 7:04 PM View: | Evolus, Inc. (EOLS) | 26-Mar-21 | Grant | 48,853 | -- | -- | 11% 440.43K to 489.28K | |
| 01-Feb-21 7:29 PM View: | Evolus, Inc. (EOLS) | 27-Jan-21 | Grant | 266,667 | -- | -- | 153% 173.76K to 440.43K | |
| 26-Jan-21 8:50 PM View: | Evolus, Inc. (EOLS) | 25-Jan-21 | Market Sale (Planned) | 8,310 | $7.46 | $61,992.60 | (5%) 182.07K to 173.76K | |
| 15-May-20 7:59 PM View: | Evolus, Inc. (EOLS) | 13-May-20 | Grant | 100,000 | -- | -- | 122% 82.07K to 182.07K | |
| 24-Jan-20 9:14 PM View: | Evolus, Inc. (EOLS) | 23-Jan-20 | Grant | 82,070 | -- | -- | 100% 0 to 82.07K | |
| 25-Jul-19 4:30 PM View: | Reshape Lifesciences Inc. (OBLN) | 23-Jul-19 | Grant | 78,125 | -- | -- | 1422% 5.49K to 83.62K | |
| 27-Aug-18 9:31 PM View: | Reshape Lifesciences Inc. (OBLN) | 23-Aug-18 | Grant | 5,494 | $1.82 | $9,999.08 | (50%) 10.99K to 5.49K | 81% |